Mail

UK markets close in 26 minutes

FTSE 100
8,117.67
-26.46(-0.32%)
FTSE 250
19,912.07
-53.32(-0.27%)
AIM
764.51
+3.77(+0.50%)
GBP/EUR
1.1686
-0.0022(-0.19%)
GBP/USD
1.2489
-0.0006(-0.05%)
Bitcoin GBP
45,894.47
-3,161.14(-6.44%)

Family finances

Who is the breadwinner in your family and does it matter?

Medpace Holdings, Inc. (MEDP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

388.88

+0.53

(+0.14%)

As of 10:59AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	12.04B
Enterprise value	11.77B
Trailing P/E	39.61
Forward P/E	36.10
PEG ratio (5-yr expected)	2.14
Price/sales (ttm)	6.30
Price/book (mrq)	17.93
Enterprise value/revenue	6.00
Enterprise value/EBITDA	30.80

Trading information

Stock price history

Beta (5Y monthly)	1.40
52-week change ³	89.00%
S&P500 52-week change ³	23.10%
52-week high ³	421.00
52-week low ³	197.39
50-day moving average ³	397.69
200-day moving average ³	305.28

Share statistics

Avg vol (3-month) ³	284.2k
Avg vol (10-day) ³	317.83k
Shares outstanding ⁵	30.98M
Implied shares outstanding ⁶	30.98M
Float ⁸	25.27M
% held by insiders ¹	18.16%
% held by institutions ¹	82.43%
Shares short (15 Apr 2024) ⁴	984.45k
Short ratio (15 Apr 2024) ⁴	5.02
Short % of float (15 Apr 2024) ⁴	4.77%
Short % of shares outstanding (15 Apr 2024) ⁴	3.18%
Shares short (prior month 15 Mar 2024) ⁴	963.64k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	15.92%
Operating margin (ttm)	20.36%

Management effectiveness

Return on assets (ttm)	13.89%
Return on equity (ttm)	61.35%

Income statement

Revenue (ttm)	1.96B
Revenue per share (ttm)	63.97
Quarterly revenue growth (yoy)	17.70%
Gross profit (ttm)	N/A
EBITDA	382.05M
Net income avi to common (ttm)	312.32M
Diluted EPS (ttm)	9.79
Quarterly earnings growth (yoy)	40.70%

Balance sheet

Total cash (mrq)	407.01M
Total cash per share (mrq)	13.17
Total debt (mrq)	158.13M
Total debt/equity (mrq)	23.55%
Current ratio (mrq)	0.78
Book value per share (mrq)	21.72

Cash flow statement

Operating cash flow (ttm)	505.98M
Levered free cash flow (ttm)	405.63M